PriceTargets.com logo

Stericycle - SRCL Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $62.25
  • Forecasted Upside: 24.72%
  • Number of Analysts: 4
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$49.91 As of 04/19/2024 01:00 AM ET
▲ +1.04 (2.13%)

This chart shows the closing price for SRCL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Stericycle Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SRCL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SRCL

Analyst Price Target is $62.25
▲ +24.72% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Stericycle in the last 3 months. The average price target is $62.25, with a high forecast of $75.00 and a low forecast of $48.00. The average price target represents a 24.72% upside from the last price of $49.91.

This chart shows the closing price for SRCL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 4 polled investment analysts is to hold stock in Stericycle. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
10/27/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
1/25/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
4/25/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
7/24/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
10/22/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
1/20/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
3/20/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
4/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/7/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$69.00Low
3/1/2024Wells Fargo & CompanyBoost TargetUnderweight ➝ Underweight$40.00 ➝ $48.00N/A
2/29/2024Stifel NicolausBoost TargetBuy ➝ Buy$70.00 ➝ $75.00Low
2/29/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$58.00 ➝ $69.00Low
2/29/2024Truist FinancialBoost TargetHold ➝ Hold$50.00 ➝ $57.00Low
12/8/2023Wells Fargo & CompanyInitiated CoverageUnderweight$40.00Low
11/3/2023Royal Bank of CanadaLower TargetOutperform ➝ Outperform$62.00 ➝ $58.00Low
9/1/2023Stifel NicolausReiterated RatingBuy ➝ Buy$70.00Low
4/17/2023Truist FinancialInitiated CoverageHold$45.00Low
2/24/2023Robert W. BairdDowngradeOutperform ➝ Neutral$65.00 ➝ $53.00Low
5/12/2022Berenberg BankDowngradeBuy ➝ Hold$95.00 ➝ $46.00Medium
4/29/2022Robert W. BairdLower Target$72.00 ➝ $63.00Medium
4/19/2022Barrington ResearchReiterated RatingMarket PerformMedium
2/25/2022Robert W. BairdLower TargetOutperform$77.00 ➝ $72.00High
11/3/2021BMO Capital MarketsLower TargetMarket Perform$75.00 ➝ $67.00High
11/3/2021Robert W. BairdLower TargetOutperform$88.00 ➝ $77.00High
8/18/2021Barrington ResearchReiterated RatingHoldHigh
11/6/2020BMO Capital MarketsBoost TargetMarket Perform$68.00 ➝ $74.00High
10/15/2020Berenberg BankInitiated CoverageBuy$76.00High
10/6/2020Raymond JamesReiterated RatingHoldHigh
8/17/2020Bank of AmericaBoost TargetUnderperform$44.00 ➝ $52.00High
8/7/2020BMO Capital MarketsBoost TargetMarket Perform$55.00 ➝ $68.00Medium
7/28/2020Barrington ResearchDowngradeHoldLow
6/18/2020Royal Bank of CanadaReiterated RatingBuyHigh
5/15/2020Barrington ResearchDowngradeOutperform ➝ Market PerformLow
5/13/2020Bank of AmericaReiterated RatingUnderperform$52.00 ➝ $44.00High
5/8/2020Royal Bank of CanadaLower TargetOutperform$75.00 ➝ $67.00Low
4/8/2020Stifel NicolausLower TargetBuy$73.00 ➝ $70.00High
3/30/2020Robert W. BairdUpgradeNeutral ➝ OutperformHigh
3/4/2020Barrington ResearchReiterated RatingBuy$69.00Medium
3/2/2020Robert W. BairdReiterated RatingHold$75.00Low
2/20/2020Robert W. BairdBoost TargetNeutral$65.00 ➝ $75.00Low
11/27/2019Royal Bank of CanadaInitiated CoverageOutperform$75.00N/A
11/27/2019Jefferies Financial GroupInitiated CoverageHold$68.00N/A
11/21/2019Jefferies Financial GroupInitiated CoverageHold$68.00High
11/21/2019Royal Bank of CanadaInitiated CoverageOutperform$75.00High
8/2/2019Robert W. BairdUpgradeUnderperform ➝ Neutral$44.00Medium
7/17/2019Bank of AmericaReiterated RatingUnderperform ➝ Underperform$46.00 ➝ $44.00Low
(Data available from 4/20/2019 forward)

News Sentiment Rating

1.08 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 15 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
9/23/2023
  • 3 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/23/2023
  • 3 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
11/22/2023
  • 6 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/22/2023
  • 7 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/21/2024
  • 11 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/20/2024
  • 13 very positive mentions
  • 16 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
3/21/2024
  • 9 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/20/2024

Current Sentiment

  • 9 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Stericycle logo
Stericycle, Inc., together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions. It also provides secure information destruction services, including document, hard drive, destruction services under the Shred-it brand. The company serves healthcare businesses, including hospitals, health systems, non-affiliate hospitals, national and corporate healthcare, physician offices, surgery centers, veterinary and dental clinics, nursing and long-term care facilities, clinics and urgent care, dialysis centers, pharmacy, lab, research centers, home health organizations, etc.; and airports and seaports, education institutions, funeral homes and crematories, government and military, banks and professional services, and other businesses. Stericycle, Inc. was incorporated in 1989 and is headquartered in Bannockburn, Illinois.
Read More

Today's Range

Now: $49.91
Low: $48.81
High: $49.91

50 Day Range

MA: $51.41
Low: $48.46
High: $55.65

52 Week Range

Now: $49.91
Low: $37.78
High: $57.06

Volume

444,564 shs

Average Volume

449,677 shs

Market Capitalization

$4.63 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09

Frequently Asked Questions

What sell-side analysts currently cover shares of Stericycle?

The following Wall Street research analysts have issued research reports on Stericycle in the last year: Royal Bank of Canada, Stifel Nicolaus, StockNews.com, Truist Financial Co., and Wells Fargo & Company.
View the latest analyst ratings for SRCL.

What is the current price target for Stericycle?

4 Wall Street analysts have set twelve-month price targets for Stericycle in the last year. Their average twelve-month price target is $62.25, suggesting a possible upside of 24.7%. Stifel Nicolaus has the highest price target set, predicting SRCL will reach $75.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $48.00 for Stericycle in the next year.
View the latest price targets for SRCL.

What is the current consensus analyst rating for Stericycle?

Stericycle currently has 1 sell rating, 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SRCL, but not buy more shares or sell existing shares.
View the latest ratings for SRCL.

What other companies compete with Stericycle?

Other companies that are similar to Stericycle include Sharps Compliance, Perma-Fix Environmental Services, Charah Solutions, Clean Harbors and Kyndryl. Learn More about companies similar to Stericycle.

How do I contact Stericycle's investor relations team?

Stericycle's physical mailing address is 2355 WAUKEGAN ROAD, BANNOCKBURN IL, 60015. The business services provider's listed phone number is (847) 367-5910 and its investor relations email address is [email protected]. The official website for Stericycle is www.stericycle.com. Learn More about contacing Stericycle investor relations.